1. No category

EUS Users Group Meeting
Wednesday 26th November 2014
08.30
Registration
08.55
Welcome and Introduction
Dr Manu Nayar, Consultant Gastroenterologist and HPB
Physician, Freeman Hospital, Newcastle
09.00
Oesophagogastric EUS: Present and future
Dr Ray McCrudden, Consultant Gastroenterologist,
Royal Bournemouth General Hospital
Chair:
Dr Raymond McCrudden
09.30
Live cases: Controversial OG case
Dr Nicholas Carroll, Consultant Radiologist and Endoscopist,
Addenbrookes Hospital, Cambridge
Mr Shaun Preston, Consultant Oesophagogastric Surgeon,
Royal Surrey County Hospital, Guildford
10.10
Eastography and Contrast EUS
Professor Adrian Saftiou. Professor of Diagnostic and
Therapeutic techniques in Gastroenterology
University do Medicine and Pharmacy, Craiova, Romania
10.40
Coffee
Chair:
Mr Colin McKay
11.00
Live cases: Solid pancreatic lesions
Dr Kofi Oppong, Consultant HPB Physician,
Freeman Hospital, Newcastle
Dr Brinder Mahon, Consultant Radiologist,
University of Birmingham NHS Trust
11.40
Recent advances in EUS guided fine needle aspiration
Mr Colin McKay, Consultant Pancreatic Surgeon
Glasgow Royal Infirmary
12.00
Advances in the diagnosis of pancreatic cysts
Dr Kofi Oppong, Consultant HPB Physician,
Freeman Hospital, Newcastle
Chair:
Dr Kofi Oppong
12.20
Live cases: Indeterminate pancreatic cysts
Dr Steve Pereira, Reader in Hepatology and Gastroenterology
University College, London
Dr Ray McCrudden, Consultant Gastroenterologist,
Royal Bournemouth General Hospital
13.00
Lunch
Chair:
Dr Elaine Henry
13.30
Training and education in EUS in the UK
Dr Nicholas Carroll, Consultant Radiologist and Endoscopist,
Addenbrookes Hospital, Cambridge
13.50
UK EUS research – how do we take it forward?
Dr Steve Pereira, Reader in Hepatology and Gastroenterology
University College, London
14.00
Drainage of peripancreatic collections
Mr Richard Charnley, Consultant Pancreatic Surgeon,
Freeman Hospital, Newcastle
Chair:
Mr Richard Charnley
14.30
Live cases: Pseudocyst drainage
Mr Tim Worthington, Consultant HPB Surgeon,
Royal Surrey County Hospital NHS Foundation Trust,
Guildford
15.30
Endoscopic pancreatic necrosectomy
Dr Manu Nayar, Consultant Gastroenterologist
Freeman Hospital, Newcastle
15.50
Future of therapeutic EUS
Dr Alberto Larghi, Digestive Endoscopy Unit
Università Cattolica del Sacro Cuore, Rome, Italy
16.20
Cytology results
Dr Louise Daborn, Consultant Cytologist
Royal Surrey County Hospital, Guildford
16.45
The future of the UK EUS users group
Dr Brinder Mahon, Consultant Radiologist,
University of Birmingham NHS Trust
17.00
Close
18.00
UK EUS users group committee meeting
19.30
UK EUS users dinner, Holiday Inn, Guildford
40th Annual Scientific Meeting
Pancreatic Society of Great Britain and Ireland
Thursday 27th November
9am Registration opens
09.30 Welcome: Mary Phillips, President PSGBI
and Cllr. David Elms, Mayor of Guildford
Session 1: Pancreatitis and benign disease
Chair:
Local
Chair:
Mr. Jeremy French, Dr Steve Pereira
Professor Nariman Karanjia, Mr Neville Menezes
09.35
Fluid management in the critically ill pancreatic patient
Dr Michael Scott, Consultant in Anaesthesia and Intensive
Care Medicine, Guildford
10.00
Debate: Resection for pain management in chronic
pancreatitis
FOR: Mr Richard Charnley, Consultant Pancreatic Surgeon,
Freeman Hospital, Newcastle
AGAINST: Professor Ajith Siriwardena, Professor of
Hepatobiliary Surgery, University of Manchester & Consultant
Hepatobiliary Surgeon, Manchester Royal Infirmary
10.30
11am
Diagnosis and management of Sphincter of Oddi
dysfunction
Dr Kofi Oppong, Consultant HPB Physician,
Freeman Hospital Newcastle
Coffee Break
Session 2: Pancreatitis and benign disease
Chair:
Local
Dr Andrew Hart, Mr Ross Carter
Dr Michelle Gallagher, Professor David Russell-Jones
Chair:
11.30
Diabetes mellitus secondary to pancreatic diseases (Type
3c diabetes)
Dr.Nils Ewald, Associate Professor of Internal Medicine /
Endocrinology and Diabetology, Justus-Liebig-University
Giessen and General Hospital Luebbecke-Rahden
11.55
Acute pancreatitis international guidelines update
Professor Robert Sutton, Professor of Surgery,
Royal Liverpool Hospital
12.20
Extreme pancreatitis
Mr Euan Dickson, Consultant Pancreatic Surgeon,
Glasgow Royal Infirmary
12.45
Lunch, posters and trade stands
Session 3: Pancreatic Cancer
Chair:
Local
Chair:
Dr Stephen Falk, Dr Sinead Duggan
Ms. Angela Riga, Mr Ben Cresswell
13.45
Cancer associated malnutrition, cachexia and sarcopenia
in the era of obesity
Dr Aoife Ryan, Lecturer in Nutritional Sciences, University
College, Cork
14.10
Management of cancer cachexia
Professor Kenneth Fearon, Professor of Surgery,
Edinburgh Royal Infirmary
14.35
Dietary therapies: Fact or fiction:
Tanya Klopper and Lindsey Bottle, Macmillian Oncology
Dietitians, Royal Surrey County Hospital, Guildford
15.00
Debate: Should patients with operable disease have neoadjuvant chemotherapy
FOR: Professor Kevin Conlon, Professor of Surgery,
Trinity College, Dublin
AGAINST: Mr Mohammed Abu-Hilal, Consultant Pancreatic
Surgeon, Southampton University Hospital
15.30
Coffee Break
Session 4: Pancreatic Cancer
Chair:
Local
Chair:
Dr. Mark Callaway, Dr Manu Nayer
Dr Andrew Hatrick, Dr Fuad Hussain, Mr Tim Worthington
16.00
PET-CT and PET-Panc update.
Professor Paula Ghaneh, Professor of Surgery,
University of Liverpool
16.25
Coeliac Axis embolisation,
Dr Nick Woodward, Consultant Interventional Radiologist,
Royal Free Hospital, London
16.50
EUS as a staging tool in pancreatic cancer.
Professor Adrian Saftiou. Professor of Diagnostic and
Therapeutic techniques in Gastroenterology
University do Medicine and Pharmacy, Craiova, Romania
17.30 Guidelines Group Meeting
Parallel Session: Clinical Nurse Specialist
Symposium
09.40
Welcome to the CNS symposium
Sophie Noble, HPB CNS, Leicester
09.45
'How to survive a whipple - potential pitfalls and avoiding
disasters.....
Graham Pinn Lead Upper GI Clinical Nurse Specialist,
Guildford
10.15
The inside story – running a support service
Di Dobson, Pancreatic Cancer Nurse Specialist, PCUK
10.45
Starting up a patient support group
Sophie Noble, HPB CNS, Leicester
11am Coffee Break
11.30
Regional Pancreatitis Network
Gill Henderson, Pancreatitis Nurse Specialist, Newcastle
12.00
Pancreatic malignancy and nutrition – a study of clinical
practice
Lynne McCallum, HPB & NET Clinical Nurse Specialist,
Manchester
12.15
What next for the nurses at Pan Soc?’ – open discussion
from the floor on nurse presentation at the Pancreas
Society – Sophie Noble, HPB CNS, Leicester
Pancreatology in Primary Care
Thursday 27th November 2014
Parallel Session 3: Pancreatology for Primary Care
13.30
Chairs:
GP Registration and Trade Stands
Professor Nariman Karanjia, Mrs Alison Stunt,
Mrs Penny Lown,
13.45
Diagnosing pancreatic cancer,
Dr Ishani Patel, Transforming Cancer Services Team, London
14.10
Surgical management of pancreatic cancer and chronic
pancreatitis,
Ms Nadeen Low, Consultant Surgeon, St Georges Hospital,
London
14.35
Post operative complications in primary care,
Mr Marcos Kostalas Surgical Registrar &
Mr Neville Menezes, Consultant HPB Surgeon, Guildford
15.00
Long term management of pancreatic exocrine
insufficiency.
Mary Phillips, HPB Specialist Dietitian, Guildford
15.30 Coffee Break
Chairs: Ms. Angela Riga, Mrs Alison Stunt, Mrs Penny Lown
16.00
Psychology of chronic pain / disease
Ms. Katherine May, Consultant Clinical Psychologist, Guildford
16.25
Managing Diabetes in the pancreatic patient
Dr Roselle Herring, Consultant Physician, Diabetes
and Endocrinology, Guildford
16.50
Supportive care for patients with pancreatic cancer
Dr Andrew Davies, Clinical Director Supportive & Palliative
Care, Guildford
17.15
Questions and Close
40th Annual Scientific Meeting
Pancreatic Society of Great Britain and Ireland
Friday 28th November
Session 5: Oral Presentations
(8 minutes plus 2 minutes for questions)
Chair:
Local
Chair:
Dr Bill Greenhalf, Professor Colin Johnson,
Ms. Nadeen Low
09.00
The role of the reverse Warburg effect and
monocarboxylate transporters in the tumour
microenvironment of pancreatic cancer.
John Moir1,2, Jelena Mann2, Steven White1
1
HPB Unit, Freeman Hospital, Newcastle Upon Tyne.
Fibrosis Lab, ICM, Newcastle University
2
09.10
A novel combined therapeutic intervention for
pancreatic cancer using oncolytic viral therapy
and photodynamic therapy.
Yazan S. Khaled1,2,3, Kathleen E. Wright1, Alan A. Melcher2,
David G. Jayne1, Andrew M. Smith3
1
Section of Translational Anaesthesia and Surgery, St James’s
University Hospital, Leeds, UK. 2Targeted and Biological Therapies,
University of Leeds, Leeds, UK. 3Department of Pancreatobiliary
Surgery, St James’s University Hospital, Leeds, UK
09.20
Predictive value of drain amylase concentration
for development of pancreatic fistula after
pancreaticoduodenectomy.
Piotr Zelga 1, Jason M Ali1, Rebecca Brais2 , Raaj K
Praseedom1, Emmanuel L Huguet1, Neville V Jamieson1,
Simon JF Harper1, Siong S Liau1, Asif Jah1
1
HPB & Transplant Surgery Unit, Cambridge University Hospitals NHS
Department of Histopathology, Cambridge University Hospitals NHS
Trust, Cambridge, UK
2
09.30
A single P53 mutation may predict survival in
intraductal papillary mucinous neoplasms of the
pancreas.
Nicholson JA1, Howes N2, Harrison S1, Büchler M3, Yan Li1,
Lane B1, Garner E1, Bullock K1, Sutton R1,2, Campbell F2,
Neoptolemos JP1,2, Greenhalf W 1.
1
NIHR Pancreas Biomedical Research Unit, Liverpool. 2Royal Liverpool
University Hospital. 3Abteilung für Allgemeine, Viszerale und
Unfallchirurgie Universität Heidelberg Deutschland
09.40
The relationships of ezrin, beta-catenin, ecadherin,K167 and vascular endothelial growth
factor immunoexpression in pancreatic carcinoma
R.Dina, S. Ndagiri,
Imperial College London
09.50
Insertion of fully-covered metal biliary stents is
associated with a higher incidence of post-ERCP
pancreatitis than plastic stents
Iain JD McCallum, Jeremy Maarschalk, John Scott, Kofi
Oppong, Manu Nayar, Richard M Charnley,
HPB surgical unit, Freeman Hospital, Newcastle upon Tyne.
10.00
Toll-like receptor-mediated IL-6 production is an
early predictor of post-operative systemic
inflammatory response syndrome (SIRS) in
patients undergoing major hepato-pancreaticobiliary (HPB) surgery.
Rajiv Lahiri 1,2, Yannick Derwa1, Zohra Bashir1, Edward Giles1,
Alastair O’Brien3, Andrew Stagg1, Satyajit Bhattacharya2,
Graham R. Foster1,2 , William Alazawi1,2
1
Department of Hepatology, Centre for Digestive Diseases, Barts and the
London School of Medicine and Dentistry, Queen Mary, University of
London. 2Barts Health HPB Centre, Royal London Hospital, 3University
College London
10.10
Outcomes following resection of metastatic
disease to the pancreas
M. Pitchairmuthu, M.S. Khan, C. Coldham, R.
Marudanayagam, R. Sutcliffe, D. Mirza, P. Muiesan, J. Isaac,
K. Roberts.
Birmingham Liver Unit, Queen Elizabeth Hospital, Birmingham
10.20 Coffee
Session 6: Pancreatic Surgery
Chair
Local
Chair
Mr Andrew Smith, Mr Keith Roberts, Professor John
Neoptolemos
Mr Tim Worthington
10.40
Laparoscopic Whipples:
Mr Zac Rahman,
Consultant Pancreatico-biliary and Advanced Laparoscopic
Upper GI Surgeon, Royal Free London NHS Foundation Trust
11.05
Achieving excellence in pancreatic surgery.
Professor Markus Bűchler, Professor of Surgery, University of
Heidelberg, Germany
Session 7: Pancreatic Cancer
Chair:
Local
Chair:
Professor Robert Sutton
Dr Christopher Tibbs, Dr Sebastian Cummins
11.30
Pain Management in pancreatic cancer,
Dr Adrian Tookman, Consultant in Palliative Medicine, Marie
Curie
11.55
Genetics and Chemotherapy,
Dr Bill Greenhalf, Reader in Molecular Biology, University of
Liverpool
12.30 Lunch
Session 8: Posters session
(3 minutes + 2 for questions)
Chair:
Local
Chair:
Mr Colin McKay, Dr Alistair Makin
Mr Rajesh Kumar
13.30
Presentation A
13.35
Presentation B
13.40
Presentation C
13.45
Presentation D
13.50
Presentation E
13.55
Presentation F
14.00
Presentation G
14.05
Presentation H
Session 9: Chemotherapy Trials Update
Chair:
Local
Chair:
Dr Kapli Kapur
Dr Tony Dhillon, Dr Marianne Illsley
14.20
SCALOP II
Radiotherapy + folfirinox + Gem-abraxane vs. chemo alone
Incorporates Nelfinavir (HIV) as radiosensitiser plus dose escalation
Dr Sebastian Cummins, Consultant Oncologist,
Royal Surrey County Hospital, Guildford
14.45
Update on clinical trials for pancreatic neuroendocrine
Tumours
Dr Richard Hubner, Consultant Oncologist and Honorary
Senior Lecturer, The Christie Hospital and University of
Manchester
15.10
Update on chemotherapy clinical trials
Dr Bristi Basu, Consultant Oncologist, Addenbrookes Hospital,
Cambridge
15.35 Coffee
16.00 AGM and presentation of prizes.
Handover of Presidency from Mary Phillips to Andrew Hart
16.30 Close
Nutrition Interest Group (NIGPS) Symposium
Friday 28th November 2014
Chair:
09.00
Practical session on tube feeding
tbc
09.30
An update on the use of glutamine: evidence on its use in
pancreatic disease.
Mr Peter Turner, Liverpool
10.00
Nutritional management of type 3c diabetes
Dr Sinead Duggan, Trinity College Dublin
10.30 Coffee
11.00
The impact of nutrition on penetrance in patients with
inherited disease of the exocrine pancreas
Dr Bill Greenhalf, Reader in Molecular Biology, University of
Liverpool
11.30
The evaluation of body composition in pancreatic disease
Mr Donal O’Connor, Senior Lecturer, Trinity College Dublin
12.30 Lunch
Use of CT scanning to detect and monitor sarcopenia
13.30
With specific software
Mr Donal O’Connor, Senior Lecturer, Trinity College, Dublin
14.00
Assessment of sarcopenia using CT imaging
Ms. Samantha Cushen, Research Dietitian, University College,
Cork
14.35
Presentation skills for Dietitians
Ms. Anne Holdoway, Specialist Dietitian and Chair of the
Parenteral and Enteral Nutrition Group (PENG) of the British
Dietetic Association
15.10
Dietitians Business Meeting
15.35
Coffee
16.00
AGM and presentation of prizes.
Handover of Presidency from Mary Phillips to Andrew Hart
16.30
Close